Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
04/29/2011
Trade Name:
Kytril Injection
Generic or Proper Name (*):
granisetron hydrochloride
Indications Studied:
Prevention of postoperative nausea and vomiting
Therapeutic Category:
Antiemetic
Study #:
1
Study Type:
Efficacy/Safety
Study Design:
Blind/Parallel Group
No Patients:
171
No Centers:
8
No Countries:
1
BPCA(B), PREA(P):
P
-
-